Arthritis is a group of conditions where there is damage caused to the joints of the body. Arthritis is the leading cause of disability in people over the age of 55. Treatment options vary depending on the type of arthritis and include physical and occupational therapy, and medications (symptomatic or targeted at the disease process causing the arthritis).
LEFLUNOMIDE (Arava) is the first isoxazol derivative approved for the treatment of rheumatoid arthritis. Leflunomide was also the first agent for rheumatoid arthritis indicated for both symptomatic improvement and retardation of structural joint damage based on radiographic evidence of its disease modifying activity.
ETORICOXIB (Arcoxia®) is a new COX-2 selective inhibitor used for chronic pain and for acute pain. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Note that approved indications differ by country
CELECOXIB (Celebrex) is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis.
INDOMETHACIN (Indocin®) is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is used to treat gout or certain types of bursitis and tendonitis. Indocin treats the symptoms of pain and inflammation. It does not treat the disease that causes those symptoms
IBUPROFEN (Motrin®) is a nonsteroidal anti-inflammatory drug. Motrin is used in adults for relief of the symptoms of rheumatoid arthritis and osteoarthritis, treatment of menstrual pain, and relief of mild to moderate pain. In children aged 6 months and older it can be given to reduce fever and relieve mild to moderate pain. It is also used to relieve the symptoms of juvenile arthritis
NAPROXEN (Naprosyn®) is used for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile arthritis. It is used to treat tendonitis, bursitis, gout, menstrual cramps, or mild to moderate pain. It may also be used for other conditions as determined by your doctor. Naprosyn treats the symptoms of pain and inflammation. It does not treat the disease that causes those symptoms
MECLOFENAMATE (meclofenamate sodium) and MEFENAMIC ACID (Ponstel®) are nonsteroidal anti-inflammatory drugs (NSAIDs). Meclofenamate helps relieve inflammation and pain associated with rheumatoid arthritis and osteoarthritis. Both drugs help relieve mild to moderate pain, including menstrual cramps or premenstrual discomfort
METHOTREXATE is a type of chemotherapy that is used to treat certain kinds of cancer and other diseases. Methotrexate affects cells that are rapidly growing such as cancer cells, cells of psoriasis, and cells in your mouth and stomach. Methotrexate is used to treat many different types of cancers including leukemias, lymphoma, breast cancer, and others. Lower dose of methotrexate may be given to patients with psoriasis or rheumatoid arthritis
DICLOFENAC (Voltaren®-XR) is an anti-inflammatory drug. Diclofenac reduces the joint pain, stiffness, inflammation, or swelling caused by rheumatoid arthritis and osteoarthritis
DICLOFENAC (Voltaren®-XR) is an anti-inflammatory drug. Diclofenac reduces the joint pain, stiffness, inflammation, or swelling caused by rheumatoid arthritis and osteoarthritis
New Study Finds HPV Vaccine Protects Against Genital Warts
(HealthDay)
HealthDay - TUESDAY, July 20 (HealthDay News) -- A new study finds that the
human papillomavirus (HPV) vaccine protects not only against the sexually
transmitted virus that causes cervical cancer, but also helps prevent
genital warts and low-grade cervical growths.
AFP - Sex workers in Cambodia are routinely unlawfully arrested and taken by police to government detention centres where they face beatings, rape and extortion, a rights group said Tuesday.
AFP - The World Bank released two studies Sunday linking cash payments to Malawian and Tanzanian youths with "significantly lower" rates of HIV and other sexually transmitted infections.
